Think about this. Median household income is now back down to $50,000. The average cost of health care for a family of four with
For more than 20 years, PNHP’s Senior Health Policy Fellow Don McCanne, M.D. wrote a daily health policy update, taking an excerpt or quote from a health care news story or analysis and commenting on its significance to the single-payer movement.
PNHP has archived Dr. McCanne’s listserv below; to read current daily analysis on a broad range of health justice topics, please visit the McCanne Health Justice Monitor website.
AP/Stanford/RWJ poll – Should health law have done more?
AP Poll: Many think health overhaul should do moreBy Ricardo Alonso-Zaldivar and Jennifer AgiestaThe Washington PostSeptember 26, 2010A new AP poll finds that Americans who
AP/Stanford/RWJ poll – Should health law have done more?
Twice as many Americans believe that the Patient Protection and Affordable Care Act should have done more to change the health care system
Uwe Reinhardt on The Perennial Quest to Lower Health Care Spending
The Perennial Quest to Lower Health Care SpendingBy Uwe ReinhardtThe New York TimesSeptember 24, 2010... the nation bravely set upon the mission of reducing the
Uwe Reinhardt on The Perennial Quest to Lower Health Care Spending
Of course, other nations do provide all of their citizens with health care at a much lower level of national health expenditures (NHE). So what
Insurers can’t survive on 20% of the premiums?
States Ask for Phase-In on Insurance ChangeBy Robert PearThe New York TimesSeptember 22, 2010It is mind-boggling to think that 21 percent of our national health
Insurers can't survive on 20% of the premiums?
States Ask for Phase-In on Insurance ChangeBy Robert PearThe New York TimesSeptember 22, 2010It is mind-boggling to think that 21 percent of our national health
Insurers can’t survive on 20% of the premiums?
It is mind-boggling to think that 21 percent of our national health expenditures (NHE) are directed to physicians and clinical services, whereas many
GlaxoSmithKline’s research priorities are for blockbusters, not patients
Products at RiskGregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M. Drazen, M.D.Editorial, The New England Journal of MedicineSeptember 19, 2010Everyone agrees, or should
GlaxoSmithKline's research priorities are for blockbusters, not patients
Products at RiskGregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M. Drazen, M.D.Editorial, The New England Journal of MedicineSeptember 19, 2010Everyone agrees, or should
GlaxoSmithKline’s research priorities are for blockbusters, not patients
Everyone agrees, or should agree, on the need for more comparative effectiveness research. We need more information about which medications provide greater benefit to patients,
Private insurers stealing from HSA accounts
Wrangling over ‘wrapping': Insurers raise rates for employers who use cost-cutting planBy Jay GreeneCrain's Detroit BusinessSeptember 19, 2010Some health insurers in Southeast Michigan are beginning